Navigation Links
Nutrition a major factor in rise in twin pregnancies

The commonly held view that IVF is the only culprit in the steady increase in the numbers of twins born over the past thirty years was challenged by a scientist speaking at the 22nd annual conference of the European Society of Human Reproduction and Embryology in Prague, Czech Republic, Wednesday 21 June 2006. Professor Robert Jansen, Medical Director of Sydney IVF, Sydney, Australia, said that his research had shown that improved nutrition, both maternal and in the lab in the case of IVF, had produced better and stronger embryos.

"Over the last 100 years, both in the UK and Australia, there has been an increase in identical twinning through the division of the embryo into two, even without IVF", he said, "and with the move to single embryo transfer with IVF this trend is obviously set to continue." Professor Jansen went on to say that the present rate of identical twinning with IVF is between one-in-a-hundred and one-in-fifty, a little over twice the rate involved when getting pregnant naturally.

Professor Jansen and his team reviewed Australian national birth statistics from 1920 to 2003 to determine the sex of babies at birth among multiple pregnancies. They found that the rate of dizygotic (DZ) twinning ?where two embryos are involved and half the twins will be of different sex - was relatively constant from 1920 until the 1960s, but there was then the well-known dramatic increase with the advent of induced ovulation and IVF ?reaching 300 in every 1000 IVF conceptions by 2000. Among monozygotic (MZ) twins, caused by embryo division (so all are of like sex), the excess rate of same-sex twins among natural conceptions has risen steadily for the last 80 years. MZ twins were relatively rare among IVF babies in the 1980s ?much less than occurs naturally ?but then rose in the nineties to reach 14 per 1000 by the year 2000.

"As IVF techniques improved there was a steady and substantial increase in MZ twinning, but starting from a low bas
'"/>

Source:European Society for Human Reproduction and Embryology


Page: 1 2 3

Related biology news :

1. Columbia research lifts major hurdle to gene therapy for cancer
2. Researchers uncover sequence of major rice pathogen
3. Emergence of cancer as major cause of childhood death in developing countries is not being adequately addressed
4. Biochemists report discovery of structure of major piece of telomerase; implications for cancer
5. Virologists make major step towards understanding the process of HIV infection
6. Biota makes major antiviral discovery
7. New gene scanning technology marks a major advance in disease research
8. LIAI scientists make major finding on potential smallpox treatment
9. MicroRNAs have shaped the evolution of the majority of mammalian genes
10. MIT: Oceans are a major gene swap-meet for plankton
11. U-M scientists identify major psoriasis susceptibility gene

Post Your Comments:
(Date:12/2/2009)...other foods have done more than raise public aware...quietly fueling a boom in the market for food test...tions. That,s the topic of the two-part cover stor...News , (C&EN) ACS, weekly newsmagazine. , C&EN A...ondent Marc Reisch point out that food safety is a...
(Date:12/2/2009)... you, at least if you are a mammal cell. , Resea...ogy Center have shown that in healthy cells, a bun...nucleus, its genetic storehouse, in its proper pla... nuclear shape, the researchers say, could provide...such as cancer, muscular dystrophy and the age-acc...
(Date:12/2/2009)... PALM HARBOR, Fla., Dec. 2 /PRNewswire-FirstCall/ ...(OTC Bulletin Board: CICI), a leading supplier of ...s automation in the financial industry* and the re...ion and Docubase Systems Inc. ("Docubase"), a lead...EDM) software provider announced today that they h...
Breaking Biology News(10 mins):A cell's 'cap' of bundled fibers could yield clues to disease 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Keep Oral Health in Check This School Year With the New Philips Sonicare for Kids Power Toothbrush 55519 1Keep Oral Health in Check This School Year With the New Philips Sonicare for Kids Power Toothbrush 55519 2Keep Oral Health in Check This School Year With the New Philips Sonicare for Kids Power Toothbrush 55519 3Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready to Use IV Bags 55516 1Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready to Use IV Bags 55516 2ANAVEX reports sigma receptor review published in leading journal 55513 1ANAVEX reports sigma receptor review published in leading journal 55513 2ANAVEX reports sigma receptor review published in leading journal 55513 3
...of the amino acid supplement L-arginine following ...nctions and measurements and may be associated wit... in the January 4 issue of JAMA. , L-arginine is a...ized as having benefits for patients with hyperten..., according to background information in the artic...
...archers at Washington University School of Medicin...Salmonella to the short list of genes regulated by...almonella riboswitch is the first to sense and res...ypes of molecules that riboswitches can detect to ... , First identified in 2002, riboswitches sense w...
...archers at Virginia Commonwealth University,s Mass..., anti-cancer agent able to overcome acquired drug...bed into cancer cells and then attacking the DNA o...earchers design a new generation of anti-cancer dr...esistance and side effects and expand the range of...
Other Biology News:Little known DNA repair enzyme may be a tumor suppressor gene 2Salmonella bacteria use RNA to assess and adjust magnesium levels 2Salmonella bacteria use RNA to assess and adjust magnesium levels 3VCU Massey Cancer Center researchers identify a new class of anti-cancer drugs based on platinum 2
(Date:12/3/2009)...PRNewswire/ -- Nikon Corporation, an innovator of ... it has signed a licensing agreement with Harvard ...ochastic Optical Reconstruction Microscopy (STORM)...on will manufacture STORM enabled microscopy syste...ikon Corporation President, Mr. Michio Kariya, and...
(Date:12/3/2009)...PRNewswire-FirstCall/ -- Inverness Medical Innovat...ling individuals to take charge of their health at...health management, has declared a dividend of $3.0...Preferred Stock ( IMA-PB). The dividend will be pa...are equal to the quotient of (a) $3.00 divided by ...
(Date:12/2/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, Neurostimulation - A Global Market Pe...4232/Neurostimulation---A-Global-Market-Perspectiv...tands enthused by the growing base of aging popula...es such as, Parkinson,s, and Alzheimer,s disease. ...
(Date:12/2/2009)... Peregrine Pharmaceutica...n of patient enrollment in a dose confirmation and...relapsed glioblastoma multiforme (GBM), the deadli...noclonal antibody linked to a radioisotope being d...tara specifically targets cells at the center of b...
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
...inancial times, good relationships with shareholde...itive relationship with current investors is espec...he best source for leading a companys next round o...t: , , Treat investors like customers! Understan...rtant in meeting their expectations. It is as impo...
...s of start-up and early-stage companies , ,In an...eadership, set business goals and prioritize steps...arly-stage companies, those activities must be acc...s their full, unwavering attention. Capital must b...erved. A business owner has to concentrate on deve...
...he University of Wisconsin-Stevens Point will rece...The WiSys Technology Foundation , an organization...Madison, has received notice from the U.S. Patent ... for a UW-Stevens Points (UWSP) associate professo...ssor of soils in UWSP s College of Natural Resour...
Other Biology Technology:Enhancing Relationships with Investors 2Management Perspectives: Outsource HR 2Management Perspectives: Outsource HR 3UW-Stevens Point Professor Receives Patent Approval For New Technology 2
Acridinium Quench Solution from Cayman Chemical
Mouse Anti-C3a / C3a des Arg Monoclonal Antibody, Unconjugated, Clone 2991 from Abcam
Rabbit Anti-NMDAR1 C2' Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-PI3K p110 delta (Poly6049) Polyclonal Antibody, Unconjugated from BioLegend
Biology Products: